Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Introduction: Cow's milk (CM) is one of the most common food allergens in Japan. The oral food challenge (OFC) of CM is important for the definite diagnosis of children with CM allergy, and it is recommended to be actively and safely performed in individuals with low CM-sIgE levels. This study aimed to investigate the safety of low-dose CM-OFC in individuals with low CM-sIgE levels and discuss the prognostic factors and appropriate approaches for assessing the starting doses of CM-OFC in these individuals.
Methods: We retrospectively analyzed 6,929 OFC tests conducted between January 1, 2017, and December 31, 2021; of which, 1,390 were CM-OFC tests. The characteristics, OFC-positive rates, CM loading, and related factors were analyzed in 138 cases involving low CM-sIgE levels. Stepwise OFC tests were conducted according to the food allergies guidelines in Japan using an open and unblinded method.
Results: Among 138 individuals with low CM-sIgE levels, 110 (79.7%) passed the OFC test without any symptoms. Among the cases with OFC-positive status, 50.0% (14/28) cases showed symptoms with low-dose OFC (30-105 mg CM protein). Moreover, complete CM elimination was associated with a significantly high OFC-positive rate, and 60.0% (12/20) of the cases involving complete CM elimination showed symptoms with low-dose OFC.
Conclusion: Eighty percent of the patients with low CM-sIgE levels safely completed the OFC test. Nevertheless, careful observation is essential during low-dose OFC test in cases with low CM-sIgE levels, especially in the cases with complete elimination. The starting dose of the OFC test should be reevaluated, and modified using baked milk or a lower dose of CM to ensure safety and early outgrowth of CM allergy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000541840 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Low-dose oral cow's milk challenge outcome for patients on complete avoidance: A multicenter study in Japan.
Pediatr Allergy Immunol
May 2025
Department of Allergy, Clinical Research Center for Allergy and Rheumatology, NHO Sagamihara National Hospital, Sagamihara, Kanagawa, Japan.
Background: Few studies have reported significant risk factors for allergic symptoms during low-dose (1-3 mL) cow's milk (CM) oral food challenges (OFCs). We investigated patients from multiple centers in Japan to identify high-risk, low-dose CM OFCs and conducted these tests at allergy-specialized facilities.
Methods: We retrospectively collected the results of the first low-dose CM OFCs performed at 10 hospitals in Japan between January and December 2019.
Safety of Oral Food Challenges for Individuals with Low Levels of Cow's Milk-Specific Immunoglobulin E Antibodies.
Int Arch Allergy Immunol
June 2025
Department of Pediatrics, Graduate School of Medical Sciences Kumamoto University, Kumamoto, Japan.
Introduction: Cow's milk (CM) is one of the most common food allergens in Japan. The oral food challenge (OFC) of CM is important for the definite diagnosis of children with CM allergy, and it is recommended to be actively and safely performed in individuals with low CM-sIgE levels. This study aimed to investigate the safety of low-dose CM-OFC in individuals with low CM-sIgE levels and discuss the prognostic factors and appropriate approaches for assessing the starting doses of CM-OFC in these individuals.
View Article and Find Full Text PDFThe Efficacy and Safety of Stepwise Oral Food Challenge in Children with Cow's Milk Allergy.
Int Arch Allergy Immunol
April 2025
Department of Pediatrics, Graduate School of Medical Sciences Kumamoto University, Kumamoto, Japan.
Introduction: Stepwise oral food challenge (OFC) tests begin with low doses of allergens and progress to full doses. We previously reported the safety and efficacy of stepwise OFC for reintroducing hen eggs. In this study, we discuss its application for cow's milk (CM) allergy.
View Article and Find Full Text PDFPredictive modeling for cow's milk allergy remission by low-dose oral immunotherapy in young children.
World Allergy Organ J
May 2024
Allergy Center, National Center for Child Health and Development, Tokyo, Japan.
Article Synopsis
- Researchers explored the effectiveness of slow low-dose oral immunotherapy (SLOIT) for treating cow's milk (CM) allergy, specifically in children under 4 years old who start treatment early.
- They created a predictive model using data from 120 children to assess the likelihood of allergy remission after 3 years, evaluating factors like age and specific blood markers.
- The model demonstrated strong accuracy in predicting remission rates, showing good performance in both internal and external validation tests, indicating its potential to enhance management of CM allergy in young kids.